Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis.
about
Spanning the genomics era: the vital role of a single institution biorepository for childhood cancer research over a decadeAdvances in managing medulloblastoma and intracranial primitive neuro-ectodermal tumorsMicroRNA biogenesis pathways in cancerLin28: primal regulator of growth and metabolism in stem cellsAdvances in the management of paediatric high-grade glioma.Treatment outcome and patterns of failure in patients of pinealoblastoma: review of literature and clinical experience from a regional cancer centre in north India.A patient tumor-derived orthotopic xenograft mouse model replicating the group 3 supratentorial primitive neuroectodermal tumor in children.MYCN amplification predicts poor outcome for patients with supratentorial primitive neuroectodermal tumors of the central nervous systemEmbryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity.CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity.New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.Outcome and prognostic factors for children with supratentorial primitive neuroectodermal tumors treated with carboplatin during radiotherapy: a report from the Children's Oncology Group.Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target.Contrast enhancement pattern predicts poor survival for patients with non-WNT/SHH medulloblastoma tumours.Integrated genomics has identified a new AT/RT-like yet INI1-positive brain tumor subtype among primary pediatric embryonal tumors.Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape.Pediatric Primitive Neuroectodermal Tumors of the Central Nervous System Differentially Express Granzyme InhibitorsTreatment Outcome and Prognostic Molecular Markers of Supratentorial Primitive Neuroectodermal Tumors.Stabilization of HIF-1α and HIF-2α, up-regulation of MYCC and accumulation of stabilized p53 constitute hallmarks of CNS-PNET animal modelRecent advances in Drosophila male germline stem cell biology.Molecular markers in pediatric neuro-oncology.New gene signatures for pediatric brain tumors: a step forward in the understanding of molecular basis of CNS PNETThe impact of molecular analysis on the survival of children with embryonal tumorsThe role of the WNT/β-catenin pathway in central nervous system primitive neuroectodermal tumours (CNS PNETs).Treatment Options for Medulloblastoma and CNS Primitive Neuroectodermal Tumor (PNET)HuCNS-SC Human NSCs Fail to Differentiate, Form Ectopic Clusters, and Provide No Cognitive Benefits in a Transgenic Model of Alzheimer's Disease.The LIN28/let-7 Pathway in Cancer.The potential for epigenetic analysis of paediatric CNS tumours to improve diagnosis, treatment and prognosis.Treatment outcome and patterns of failure in patients of non-pineal supratentorial primitive neuroectodermal tumor: review of literature and clinical experience form a regional cancer center in north India.Pre-clinical drug screen reveals topotecan, actinomycin D and volasertib as potential new therapeutic candidates for ETMR brain tumor patients.The transcriptional modulator HMGA2 promotes stemness and tumorigenicity in glioblastoma.miR-367 promotes proliferation and stem-like traits in medulloblastoma cells.Coagulation and angiogenic gene expression profiles are defined by molecular subgroups of medulloblastoma: evidence for growth factor-thrombin cross-talk.A novel C19MC amplified cell line links Lin28/let-7 to mTOR signaling in embryonal tumor with multilayered rosettes.Embryonal tumors with multilayered rosettes in children: the SFCE experience.High Incidence of Veno-Occlusive Disease With Myeloablative Chemotherapy Following Craniospinal Irradiation in Children With Newly Diagnosed High-Risk CNS Embryonal Tumors: A Report From the Children's Oncology Group (CCG-99702).LIN28A facilitates the transformation of human neural stem cells and promotes glioblastoma tumorigenesis through a pro-invasive genetic program.Histologically defined central nervous system primitive neuro-ectodermal tumours (CNS-PNETs) display heterogeneous DNA methylation profiles and show relationships to other paediatric brain tumour typesLIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR)Integrative genomics reveals molecular and clinical heterogeneity in central nervous system primitive neuroectodermal tumors in children.
P2860
Q26770333-96C68215-A0A4-4254-96CF-7EA3309AC580Q26866408-DB91DC5E-F3E5-47B8-9ABD-21FC907E5033Q27013841-2C6B4796-022E-42EF-83F6-D23A238CE236Q28288454-2BF1C316-CE2C-4F85-AE8F-9B856CCE50DCQ30870633-447FC67E-A92A-4512-A45F-8835C5AEE5B1Q30964830-16FA9B64-3FB8-4948-82DD-B15063AF71D0Q33616598-794054AB-4A16-4CA3-9448-82000D3EA71EQ33753435-C321E045-869F-45F9-8FA8-8C863D0DFB33Q33917715-E9B49A9A-4DCC-4F96-8C24-0FF383FBB1CCQ34157312-A0CCBC88-088E-404C-8E93-10087C0A389AQ34515911-8D1DEFDB-F8A2-481E-9B52-78C9771599B6Q35224388-A451376E-972D-45EC-A77A-4B3F5EF631CFQ35550199-FEB70377-D0DB-4F47-882A-CCC1B4345A3CQ35630417-EB08FCE9-24D1-4C9C-90DE-781697BE1281Q35673653-7DA8E2F0-255B-417D-8D70-2EA05A0B7C49Q35754390-113DFDE7-7DA7-45A8-B68B-B287DEAD0527Q35952443-7BE94217-BE8E-443B-B8E7-ACD4D6F912A5Q35988515-17CE78D6-A6D8-4DE8-8BE9-5E7DD66E4E8DQ36293972-6353A533-B782-47FA-B464-8AE041A1A5D4Q36312067-EB3944C3-8A69-43DC-8B68-C60E823C77EFQ36344704-8171F750-3899-4D72-AF0A-2FDF11EF5A88Q36508269-366EE222-B545-4ED6-B24A-15E09FE6CB06Q36508502-E6B6A5E1-8682-4E0E-94B3-D2FB0291F577Q36896072-EBCBF159-8311-47E2-8922-83573994CB0AQ37261835-A84C5F0C-083B-482C-AF8B-E060C957C343Q37644720-605CA8F0-EBC2-4C87-A537-BF736461EE7EQ37723361-C7E762F6-C220-419A-8561-E1D4DC313C86Q38326253-54CA26EF-9CB7-4979-8EA9-ADB6D60D607CQ38492284-D97E212D-0396-495A-B1FC-0D262C99C6D4Q38686509-9AA6F19D-EDD5-4A09-B152-9A45865EA6F6Q38776367-ACDF4BB5-DF66-44E7-913B-065F8408546EQ38845733-649A8569-A22B-4652-8E68-740020A17026Q38962343-86721F84-B78A-4D1D-B348-D07316316A5EQ39047678-47474AA6-8989-48A6-890D-313CFB253238Q40464649-1D2ED67A-DEAF-4BDF-B241-3F55700E4BCDQ40744398-4CF49628-EBFB-427D-94B5-C28E04A6B447Q41978713-FB4CCC59-B474-4C65-933C-543ECC3796BAQ41998084-A14D792B-6E76-4C58-B3CD-81FF54DD9B80Q42085653-B6FEC240-EB8E-46F7-A38C-6EF083774A9BQ43066193-A9977892-547F-4C76-B0AE-97B97837D511
P2860
Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Markers of survival and metast ...... integrative genomic analysis.
@ast
Markers of survival and metast ...... integrative genomic analysis.
@en
type
label
Markers of survival and metast ...... integrative genomic analysis.
@ast
Markers of survival and metast ...... integrative genomic analysis.
@en
prefLabel
Markers of survival and metast ...... integrative genomic analysis.
@ast
Markers of survival and metast ...... integrative genomic analysis.
@en
P2093
P2860
P50
P1433
P1476
Markers of survival and metast ...... integrative genomic analysis.
@en
P2093
Amar Gajjar
Andrey Korshunov
Annie Huang
Ching C Lau
Chris Jones
Cynthia E Hawkins
Daniel Picard
Helen Toledano
Hideo Nakamura
Ho-Keung Ng
P2860
P304
P356
10.1016/S1470-2045(12)70257-7
P50
P577
2012-06-11T00:00:00Z